The Meals and Drug Administration introduced Wednesday that it has approved a booster shot for Novavax’s Covid-19 vaccine.
Not like the most recent boosters from Pfizer-BioNTech and Moderna, which goal each the unique pressure of SARS-CoV-2 and the Omicron BA.4/5 variants, the Novavax booster solely targets the unique pressure. The corporate introduced in late Could that it was finding out an Omicron-targeting pressure, in addition to a bivalent booster. However outcomes of that work haven’t been revealed to this point.
The booster shot is permitted for individuals 18 and older who, for medical or accessibility causes, can’t take one of many bivalent messenger RNA Covid boosters, or who in any other case wouldn’t take a booster.
commercial
The booster shot is to be given a minimum of six months after the administration of the second dose of a major sequence of Covid vaccine.
The director of the Facilities for Illness Management and Prevention, Rochelle Walensky, should suggest use of the vaccine earlier than booster doses may be administered. That’s anticipated to occur quickly.
commercial
Novavax has introduced knowledge to the FDA that it mentioned reveals that its vaccine induces a broadly cross-protective response to numerous strains of SARS-2, together with Omicron variants BA.1, BA.2, and BA.5. Knowledge from the CDC point out that BA.5 stays the dominant virus pressure at current, although a half-dozen or so different Omicron variants are beginning to change it. BA.1 and BA.2 viruses not seem like circulating on this nation.
Novavax’s Covid vaccine confirmed extremely favorable ends in preliminary trials, with efficacy near that proven by the mRNA vaccines. The Novavax vaccine is made utilizing a distinct strategy, using recombinant nanoparticle expertise. Its vaccine additionally makes use of an adjuvant, a compound that enhances the immune response the vaccine generates.
The vaccine, which is saved at fridge temperature, is given as a major sequence as two doses administered three weeks aside.
Previous to the pandemic Novavax was seen as an organization with a promising expertise, however no confirmed monitor file — having by no means introduced a vaccine to market — and no manufacturing services of its personal. It has struggled mightily to supply its product because it entered the race to develop a Covid vaccine, solely incomes FDA authorization for its vaccine in July, a full 19 months after Pfizer and Moderna.
It has been hoped that the vaccine would entice individuals who have resisted getting mRNA vaccines to get vaccinated towards Covid, however to this point the variety of takers on this nation has been low. The newest knowledge from the CDC reveals that simply over 35,000 doses of the vaccine have been administered. Greater than 372 million doses of Pfizer’s vaccine and practically 236 million doses of Moderna’s vaccine have been given within the U.S.
Novavax has been authorised in a minimum of two nations — Canada and South Korea — and has been approved for emergency use in a variety of others, together with Israel, Taiwan, Switzerland, the UK, South Africa, New Zealand, and within the European Union.
∼ Correction: An earlier model of this text incorrectly said the Novavax booster was not accessible to individuals who had obtained an mRNA vaccine as their major sequence.
Get your day by day dose of well being and drugs each weekday with STAT’s free e-newsletter Morning Rounds. Join right here.